130.22
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Aptargroup Inc stock is traded at $130.22, with a volume of 311.28K.
It is down -0.54% in the last 24 hours and down -3.70% over the past month.
Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. With the bulk of its annual net sales coming from Europe (49% of sales) and the United States (32%), Aptar aims to increase its presence in Asia (11%) and Latin America (8%). It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.
See More
Previous Close:
$130.93
Open:
$130.99
24h Volume:
311.28K
Relative Volume:
0.71
Market Cap:
$8.58B
Revenue:
$3.55B
Net Income/Loss:
$370.24M
P/E Ratio:
23.76
EPS:
5.48
Net Cash Flow:
$355.96M
1W Performance:
-1.26%
1M Performance:
-3.70%
6M Performance:
-9.64%
1Y Performance:
-19.39%
Aptargroup Inc Stock (ATR) Company Profile
Name
Aptargroup Inc
Sector
Industry
Phone
(815) 477-0424
Address
265 EXCHANGE DRIVE, CRYSTAL LAKE, IL
Compare ATR with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
ATR
Aptargroup Inc
|
130.22 | 8.63B | 3.55B | 370.24M | 355.96M | 5.48 |
![]()
ISRG
Intuitive Surgical Inc
|
435.73 | 154.00B | 9.15B | 2.63B | 1.99B | 7.1661 |
![]()
BDX
Becton Dickinson Co
|
186.66 | 53.47B | 21.39B | 1.61B | 2.55B | 5.5609 |
![]()
RMD
Resmed Inc
|
273.01 | 39.70B | 5.15B | 1.40B | 1.65B | 9.5082 |
![]()
ALC
Alcon Inc
|
72.60 | 35.62B | 10.03B | 1.07B | 1.39B | 2.1549 |
![]()
WST
West Pharmaceutical Services Inc
|
262.47 | 18.82B | 2.96B | 487.70M | 344.00M | 6.6758 |
Aptargroup Inc Stock (ATR) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Sep-04-25 | Initiated | KeyBanc Capital Markets | Overweight |
Jan-07-25 | Initiated | Raymond James | Outperform |
Jan-06-25 | Downgrade | BofA Securities | Buy → Neutral |
Oct-14-24 | Upgrade | Jefferies | Hold → Buy |
Apr-29-24 | Upgrade | William Blair | Mkt Perform → Outperform |
Jan-03-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
Aug-02-21 | Downgrade | William Blair | Outperform → Mkt Perform |
Apr-14-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
Oct-14-20 | Initiated | Seaport Global Securities | Neutral |
Apr-27-20 | Upgrade | BofA/Merrill | Neutral → Buy |
Mar-25-20 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
Mar-04-20 | Upgrade | Wells Fargo | Equal Weight → Overweight |
Feb-26-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Jul-08-19 | Initiated | Morgan Stanley | Overweight |
Apr-05-19 | Reiterated | BofA/Merrill | Underperform |
Feb-27-19 | Upgrade | Robert W. Baird | Neutral → Outperform |
May-18-18 | Initiated | Jefferies | Hold |
Dec-07-16 | Downgrade | BofA/Merrill | Buy → Underperform |
Oct-13-16 | Initiated | Jefferies | Hold |
Jan-05-16 | Downgrade | Robert W. Baird | Outperform → Neutral |
Nov-02-15 | Upgrade | Deutsche Bank | Hold → Buy |
Sep-15-15 | Upgrade | BofA/Merrill | Neutral → Buy |
May-01-15 | Upgrade | BofA/Merrill | Underperform → Neutral |
Feb-19-13 | Reiterated | Deutsche Bank | Hold |
Jan-08-13 | Upgrade | Robert W. Baird | Neutral → Outperform |
Jul-10-12 | Downgrade | KeyBanc Capital Mkts | Buy → Hold |
Apr-11-12 | Initiated | KeyBanc Capital Mkts | Buy |
Jun-13-11 | Upgrade | KeyBanc Capital Mkts | Hold → Buy |
View All
Aptargroup Inc Stock (ATR) Latest News
Key metrics from AptarGroup Inc.’s quarterly data2025 Trade Ideas & High Win Rate Trade Tips - newser.com
Is AptarGroup Inc. stock supported by strong cash flowsJuly 2025 Highlights & Reliable Entry Point Trade Alerts - newser.com
Candlestick signals on AptarGroup Inc. stock todayProfit Target & AI Enhanced Trading Alerts - newser.com
Tick level data insight on AptarGroup Inc. volatilityWeekly Trading Summary & Fast Entry Momentum Trade Alerts - newser.com
How AptarGroup Inc. stock performs in interest rate cyclesJuly 2025 Action & Risk Managed Trade Strategies - newser.com
Will AptarGroup Inc. stock recover faster than marketJuly 2025 Momentum & Fast Gain Swing Alerts - newser.com
Will AptarGroup Inc. (AGT) stock see insider accumulationIndex Update & AI Driven Stock Movement Reports - newser.com
Will AptarGroup Inc. benefit from macro trends2025 Major Catalysts & Growth Focused Entry Reports - newser.com
How high can AptarGroup Inc. stock go2025 Analyst Calls & Capital Protection Trading Alerts - newser.com
Should AptarGroup’s (ATR) Nasus Pharma Partnership Shift Investor Expectations for Pharma Segment Innovation? - simplywall.st
Is AptarGroup Inc. (AGT) stock worth buying before Fed action2025 Trading Volume Trends & Real-Time Market Sentiment Alerts - newser.com
Will AptarGroup Inc. stock rise with strong economyProfit Target & Community Consensus Trade Alerts - newser.com
Technical analysis overview for AptarGroup Inc. stockMarket Growth Report & Pattern Based Trade Signal System - newser.com
What moving averages say about AptarGroup Inc.2025 Performance Recap & Weekly High Momentum Picks - newser.com
Will breakout in AptarGroup Inc. lead to full recoveryMarket Performance Report & AI Forecast for Swing Trade Picks - newser.com
Can AptarGroup Inc. stock deliver sustainable ROEJuly 2025 Earnings & Daily Stock Trend Reports - newser.com
Nasus Pharma Expands Collaboration with Aptar for Intranasal Epinephrine Program - TipRanks
AptarGroup (ATR) Partners with Nasus Pharma for NS002 Developmen - GuruFocus
Nasus Pharma partners with Aptar for intranasal epinephrine development By Investing.com - Investing.com Canada
Nasus Pharma partners with Aptar for intranasal epinephrine development - Investing.com
AptarGroup stock hits 52-week low at 130.24 USD By Investing.com - Investing.com Canada
AptarGroup stock hits 52-week low at 130.24 USD - Investing.com
Aptar Beauty and Clarins Launch the New Reloadable Total Eye Lift - Aptar
AptarGroup : CDP Corporate Questionnaire (2025 0916 CDP 2025) - MarketScreener
Market reaction to AptarGroup Inc.’s recent newsEarnings Miss & Community Driven Trade Alerts - newser.com
AptarGroup Inc. stock volume spike explainedRate Cut & High Return Trade Opportunity Guides - newser.com
How rising interest rates impact AptarGroup Inc. stockJuly 2025 Rallies & Comprehensive Market Scan Reports - newser.com
Will AptarGroup Inc. (AGT) stock announce special dividendWeekly Trend Report & Fast Moving Market Watchlists - newser.com
Is AptarGroup Inc. forming a bottoming baseInflation Watch & Verified Stock Trade Ideas - newser.com
Will AptarGroup Inc. stock profit from automation wavePortfolio Risk Report & Weekly Watchlist of Top Performers - newser.com
Does AptarGroup Inc. fit your quant trading modelTrade Ideas & Safe Capital Preservation Plans - newser.com
Epinephrine nasal spray maker ARS sues Aptar alleging device supply monopoly - Reuters
Aptargroup Inc Stock (ATR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):